Policy Supported
Letters Supported & Letters Submitted
Cigna’s Letters to Patients and Providers on Cosentyx
Patient groups, advocates, and providers have seen disturbing media reports about Cigna’s recent letter to patients and providers regarding the use of Cosentyx. In the letter, patients are encouraged to switch to a Cigna-preferred drug, as Cosentyx was removed from...
An ACT RELATING TO INSURANCE – PRESCRIPTION DRUG BENEFITS
We, the undersigned, want to express our support for S0859, a much-needed bill that will protect patient access to co-pay assistance programs many Rhode Islanders depend on to cover significant portions of prescription medicine co-pays. We thank you for co-sponsoring...
International Reference Pricing and Alzheimer’s Disease
The undersigned organizations are writing, in anticipation of the reintroduction of the Elijah E. Cummings Lower Drug Costs Now Act (i.e., H.R. 3), to urge Congress to keep any international reference pricing proposals (including "International Pricing Index" or...
Cigna’s Recent Letter to Patients and Providers Regarding the Use of Cosentyx
Patient groups, advocates, and providers have seen disturbing media reports about Cigna’s recent letter to patients and providers regarding the use of Cosentyx. In the letter, patients are encouraged to switch to a Cigna-preferred drug, as Cosentyx was removed from...
Patient and Provider Group Rebate Wall Sign On Letter
On behalf of the undersigned organizations representing diverse patient and provider stakeholders who are concerned with the effects of rebate walls on patient treatment access, we greatly appreciate your leadership on critical efforts to protect patient well-being....
HHS Notice of Benefit and Payment Parameters for 2022
On January 20, the Biden administration issued a “regulatory freeze” memo asking agencies to consider postponing rules that have been published in the Federal Register but have not yet taken effect and open a 30-day comment period. This would allow President Biden’s...
Memorandum in Support to Prevent Harmful and Unfair COPAY Accumulator Policies
New York has a strong record in leading the nation in providing access to affordable health coverage. Despite the strides the state has made in expanding coverage, many New Yorkers still face hardship when faced with prescription drug costs. New Yorkers and others...
Comment Letter for the CMMI Demonstration Project on the Six Protected Classes
Patients Rising Now is a national nonprofit organization dedicated to advocating for the rights of patients with chronic and life-threatening illnesses. We support policies aimed at advancing patient access to and affordability of healthcare. We are writing to ask...
UnitedHealthcare’s Mid-Year Change in Coverage a Concern for Stable Patients
The American Autoimmune Related Diseases Association (AARDA), other patient advocates and providers understand that UnitedHealthcare intends to move Remicade from preferred to non-preferred coverage in February 2021. This abrupt change by the plan could be disruptive...
Rescind the Current Ban on the Use of Copay Cards
On behalf of the undersigned organizations and over 45 million persons covered by Medicare Part D and their family caregivers, we urge you to rescind the current ban on the use of copay cards in the Medicare Part D program at least through the current Novel...
Patient Advocate Comments – CMS Medicaid NPRM – Copay Provision
The undersigned organizations, on behalf of tens of millions of Americans with serious illnesses, chronic conditions, and disabilities, are submitting this formal comment pertaining to your recent Notice of Proposed Rule Making. While we appreciate the Centers for...
Recent Policy Changes in the 2021 Notice of Benefit and Payment Parameters (NBPP)
Throughout the country, millions of patients rely on cost-sharing assistance programs, which reduce patient out-of-pocket costs for prescription medications. For many individuals, these cost reductions are significant, allowing them to afford the medications necessary...